Hub : Traits :

Systolic blood pressure, automated reading

1812 significantly associated models · 410 unique genes.

Significant Loci

#	chr	p0	p1	# assoc genes	# joint genes	best TWAS P	best SNP P	cond SNP P	% var exp	joint genes
1	1	752566	2544640	9	3	4.2e-10	2.0e-08	2.5e-01	96	LOC441869 PUSL1 RP5-890O3.9
2	1	7715776	9571422	2	1	2.3e-11	9.3e-11	1.0e+00	100	RERE
3	1	11032827	12600396	6	3	9.9e-43	1.6e-39	4.2e-01	100	CLCN6 NPPA
4	1	15314120	16760037	2	1	2.3e-08	8.5e-08	2.1e-02	82	PLEKHM2
5	1	43073464	44618031	9	1	1.0e-10	8.1e-11	1.0e+00	100	SZT2
6	1	59073430	60921087	1	1	7.2e-11	4.3e-15	7.3e-08	53	FGGY
7	1	66304567	67908644	1	1	2.1e-08	9.4e-09	1.2e-01	93	SGIP1
8	1	88453303	90145331	3	1	4.8e-11	8.0e-11	3.7e-02	90	GTF2B
9	1	112312154	114366434	4	3	1.2e-10	8.7e-15	4.6e-08	50	RHOC SLC16A1 WNT2B
10	1	183961643	185416670	1	1	7.9e-09	1.2e-06	9.1e-01	100	EDEM3
11	1	209059239	210482140	1	1	1.8e-07	3.0e-08	6.3e-02	89	CAMK1G
12	1	230142626	231548480	1	1	1.2e-15	4.8e-12	2.9e-01	98	AGT
13	2	19492579	20908767	1	1	2.5e-08	7.7e-13	1.1e-06	54	MATN3
14	2	23453834	25692112	5	2	6.8e-10	1.6e-09	7.7e-01	100	ADCY3 UBXN2A
15	2	55617604	56167809	1	1	6.0e-08	1.0e-07	2.2e-02	81	PNPT1
16	2	64586858	66008960	1	1	5.7e-13	1.7e-12	1.0e+00	100	CEP68
17	2	113686416	115095488	1	1	3.8e-08	3.0e-07	3.3e-01	96	RABL2A
18	2	134794256	136403272	4	1	2.1e-08	8.6e-08	2.8e-01	96	LOC100129961
19	2	158332890	160006143	1	1	2.8e-07	6.4e-09	2.1e-04	59	CCDC148
20	2	218421136	219878756	3	1	8.0e-09	9.3e-08	4.7e-07	11	TMBIM1
21	3	10617048	12457119	2	1	1.4e-09	8.0e-12	8.4e-04	76	VGLL4
22	3	26720690	28211713	1	2	8.9e-09	1.8e-08	5.3e-01	99	SLC4A7
23	3	40594264	42967174	2	1	1.2e-09	2.9e-09	3.2e-01	97	ULK4
24	3	47204518	50085153	9	2	3.2e-10	1.1e-08	3.8e-01	98	GPX1 NME6
25	3	52047421	53489090	2	1	2.9e-07	1.3e-06	3.0e-04	44	TMEM110
26	3	123792729	125314016	1	1	1.6e-12	3.0e-11	6.9e-01	100	ITGB5
27	3	157125828	158980014	2	1	5.5e-08	6.4e-07	4.4e-01	98	RSRC1
28	3	159455723	160866230	2	1	9.6e-08	3.7e-07	1.6e-01	92	IFT80
29	4	14310407	15767752	1	1	3.0e-07	2.9e-07	2.3e-02	80	CPEB2
30	4	17104059	18507692	1	1	7.3e-10	1.4e-08	8.0e-02	90	DCAF16
31	4	47802595	53472171	6	1	8.8e-13	5.1e-13	1.0e-01	95	OCIAD1
32	4	69893854	70120699	2	1	6.0e-10	7.0e-10	1.0e+00	100	UGT2B7
33	4	80488345	82578407	2	1	4.1e-17	2.6e-41	6.5e-26	39	C4orf22
34	4	85698680	87621473	2	1	1.9e-18	3.4e-16	1.4e-01	97	ARHGAP24
35	4	145982563	147552337	1	1	8.2e-08	4.9e-09	1.6e-02	83	ZNF827
36	4	155890241	157354250	2	1	1.4e-13	2.5e-13	2.4e-03	83	RP11-588K22.2
37	5	61359597	62166774	3	1	1.5e-08	7.8e-09	1.0e+00	100	IPO11
38	5	70709459	72201058	1	2	4.4e-08	1.7e-06	8.2e-01	100	MAP1B
39	5	121488203	123054717	1	1	1.3e-09	4.6e-14	4.0e-07	55	SNX24
40	5	147516165	148067337	1	1	1.8e-07	4.4e-07	5.4e-01	98	FBXO38
41	6	12595275	13990267	1	1	1.1e-07	3.6e-08	7.7e-02	90	RP1-257A7.5
42	6	25285943	26689223	1	1	6.2e-08	2.0e-09	3.0e-04	64	U91328.21
43	6	34840398	35353523	1	1	5.4e-08	1.4e-07	2.7e-01	96	TCP11
44	6	55222696	56954550	1	1	1.9e-08	7.1e-08	2.9e-03	69	COL21A1
45	6	78880271	80486611	2	1	8.8e-09	1.6e-08	1.0e+00	100	IRAK1BP1
46	6	96275538	97756290	3	1	4.9e-12	2.8e-12	1.4e-01	95	FHL5
47	6	117078784	118726243	3	1	1.4e-14	3.6e-10	7.8e-02	92	GOPC
48	6	146826657	148410391	2	1	1.1e-08	1.5e-08	9.5e-02	91	STXBP5
49	7	23913624	25432157	1	1	1.6e-08	6.9e-09	1.0e+00	100	MPP6
50	7	26969253	27533292	2	1	5.0e-12	6.1e-14	1.3e-04	74	HOXA10
51	7	45709404	46210616	1	1	1.4e-08	3.2e-10	1.3e-03	74	IGFBP3
52	7	74339397	76209459	5	1	1.4e-07	2.7e-07	5.9e-01	99	PMS2L3
53	7	91142400	93160671	6	2	1.2e-14	2.9e-15	1.0e+00	100	CDK6 GATAD1
54	7	130307434	131708281	1	1	7.8e-11	9.5e-13	1.0e-04	70	MKLN1-AS2
55	8	8092025	13120332	26	1	4.5e-14	1.4e-15	5.6e-07	61	FDFT1
56	8	21600469	23096594	1	1	2.2e-07	1.2e-06	1.0e+00	100	PPP3CC
57	8	119737284	121136001	1	1	1.3e-11	7.5e-10	3.3e-02	88	NOV
58	9	33414173	34824830	1	1	9.5e-09	2.6e-07	3.9e-02	84	DCAF12
59	10	11693166	13569805	1	1	1.4e-07	1.1e-07	9.0e-02	90	CAMK1D
60	10	18221643	19637020	3	2	1.5e-11	2.7e-21	1.5e-13	39	CACNB2 NSUN6
61	10	63856856	65606229	3	1	7.1e-14	3.3e-13	1.0e+00	100	ADO
62	10	68861272	70358745	3	1	5.2e-09	9.9e-09	3.5e-02	86	DNAJC12
63	10	74714177	77160682	10	1	5.9e-15	1.6e-11	1.1e-01	94	FUT11
64	10	95379543	97524313	4	2	4.4e-11	1.3e-17	4.6e-06	71	HELLS NOC3L
65	10	103313599	106371784	18	9	9.9e-25	1.4e-28	1.0e+00	100	AS3MT C10orf26 CNNM2 CYP17A1-AS1 INA NT5C2 PCGF6 RP11-541N10.3
66	10	115555541	116053000	1	1	1.1e-07	1.8e-13	9.8e-09	39	ADRB1
67	11	1213806	2705175	5	3	2.5e-22	7.9e-23	6.4e-03	92	LSP1 TNNI2 TNNT3
68	11	9003306	11027552	2	2	1.6e-12	5.8e-16	8.2e-03	89	ADM SWAP70
69	11	16709350	18095815	3	1	2.0e-08	1.0e-06	4.5e-01	98	DKFZp686O24166
70	11	46033104	48783497	17	1	3.0e-13	1.3e-13	6.6e-04	79	FNBP4
71	11	56774260	58178587	2	1	6.5e-11	4.5e-08	6.3e-02	88	MED19
72	11	62922117	64374241	1	1	1.6e-07	4.4e-06	7.7e-02	85	MARK2
73	11	64948277	66333072	5	2	1.2e-08	1.3e-07	3.9e-01	97	SIPA1 SNX32
74	11	99859184	101559718	2	1	3.5e-39	1.6e-34	9.7e-01	100	TMEM133
75	11	106485489	108027561	2	1	1.9e-14	1.2e-17	5.1e-05	78	CWF19L2
76	11	112440560	113841003	1	1	4.5e-08	1.2e-10	2.8e-05	58	NCAM1-AS1
77	11	129575976	130992111	1	1	2.6e-11	1.2e-15	8.8e-06	69	ADAMTS8
78	12	26425752	27828938	1	1	7.4e-08	5.1e-07	8.6e-06	22	RP11-421F16.3
79	12	47927495	48462455	1	1	1.6e-07	6.2e-06	6.7e-01	99	HDAC7
80	12	49356534	51256065	5	2	2.5e-09	2.4e-09	1.0e+00	100	CERS5 FMNL3
81	12	54158993	54653258	1	1	6.5e-08	1.5e-08	7.9e-02	90	HOXC8
82	12	89116708	90799212	3	1	1.0e-21	8.5e-30	1.1e-09	71	ATP2B1
83	12	109670468	113517494	17	2	8.9e-21	2.5e-18	6.2e-03	90	SH2B3 TRPV4
84	13	114302502	115106996	2	1	1.8e-08	4.2e-08	2.5e-01	96	UPF3A
85	14	22670975	24147787	4	1	2.0e-11	6.1e-11	3.4e-06	50	RBM23
86	14	99506342	101101120	2	2	2.0e-09	3.4e-07	6.8e-01	99	CYP46A1 EML1
87	15	39530508	42749023	13	2	8.3e-13	9.5e-12	1.3e-02	87	CHP EIF2AK4
88	15	62716641	64123980	2	1	2.2e-09	2.6e-08	2.5e-01	96	LACTB
89	15	74042497	75930199	10	1	1.1e-14	4.5e-15	6.5e-02	94	UBL7
90	15	80272818	81737095	2	2	1.2e-11	4.2e-15	2.3e-01	98	ABHD17C FAM108C1
91	15	90712555	92135418	3	1	2.7e-34	2.5e-27	7.9e-01	100	FES
92	16	1381714	2713729	1	1	9.3e-09	3.7e-09	1.3e-01	93	SLC9A3R2
93	16	3025993	5593819	5	4	2.5e-08	2.2e-09	6.8e-02	91	AC006111.1 GLYR1 MGRN1 NAT15
94	16	24042724	25620010	2	1	4.5e-16	7.8e-15	1.0e+00	100	SLC5A11
95	16	69337091	71292172	5	1	9.7e-09	2.6e-07	1.1e-01	90	RP11-296I10.6
96	16	74578110	76197034	4	1	2.3e-12	4.0e-13	1.0e+00	100	CFDP1
97	16	87741662	88356427	1	1	3.3e-09	3.4e-09	1.0e+00	100	BANP
98	17	554080	3011213	6	2	2.2e-15	8.1e-14	4.3e-02	93	CRK SMG6
99	17	6397773	8173767	12	6	5.6e-11	5.2e-10	1.0e+00	100	ACADVL DLG4 DULLARD SENP3 SLC2A4 TNFSF12-TNFSF13
100	17	42413481	47688526	40	11	8.1e-21	1.1e-19	NaN	NaN	ARL17A DCAKD FMNL1 HOXB9 ITGB3 LRRC37A4P MAPT RP11-6N17.6 UBE2Z
101	17	57276710	58660283	1	1	9.3e-08	5.8e-08	1.1e-06	20	RPS6KB1
102	17	58828402	60172573	3	1	1.1e-10	2.3e-10	7.8e-02	92	RP11-332H18.4
103	17	61527677	62983145	1	1	1.8e-11	1.1e-09	1.7e-01	95	TEX2
104	17	75977988	77462467	2	1	1.8e-09	2.6e-10	1.9e-02	86	USP36
105	19	1086043	2923263	3	2	9.9e-09	8.5e-09	1.0e+00	100	ATP8B3 PLEKHJ1
106	19	45585167	46967227	1	1	1.3e-07	1.5e-06	7.0e-01	99	AC074212.6
107	20	57525478	58079512	1	1	4.8e-09	1.8e-16	5.7e-09	50	ZNF831
108	20	61522825	62912463	9	4	7.3e-13	2.3e-10	1.7e-01	95	LIME1 RGS19 TCEA2 ZBTB46

Pleiotropic Associations

Trait	chisq ratio	# genes⁺	# genes⁺⁺	% genes⁺⁺	corr	corr P	genes
Bipolar Disorder or Schizophrenia	2.25	11	7	15.6	0.23	4.9e-01	AS3MT C10orf26 CERS5 CNNM2 CYP17A1-AS1 FES MARK2 MPP6 NT5C2 TMEM110 U91328.21
Depressed Affect (Nagel 2018)	2.37	7	4	8.9	-0.08	8.4e-01	FMNL1 FNBP4 GPX1 LRRC37A4P MAPT RERE SH2B3
Depression (Nagel 2018)	1.57	2	1	2.2	0.00	1.0e+00	MAPT RERE
Intelligence (Savage-Jansen 2018)	1.43	9	3	6.7	-0.33	3.4e-01	ARL17A CYP17A1-AS1 DCAF16 EDEM3 GPX1 GTF2B MAPT SLC5A11 SZT2
Neuroticism (Nagel 2018)	2.76	11	3	6.7	-0.07	8.2e-01	ADM AS3MT C10orf26 CNNM2 CYP17A1-AS1 FMNL1 GPX1 LRRC37A4P MAPT RERE U91328.21
Schizophrenia (2018)	2.32	9	6	13.3	0.53	1.4e-01	AS3MT C10orf26 CNNM2 CYP17A1-AS1 FES MARK2 NT5C2 RERE U91328.21
Schizophrenia vs Biploar Disorder	1.77	1	0	0.0	0.00	1.0e+00	CNNM2
Worry (Nagel 2018)	2.43	10	7	15.6	0.33	3.0e-01	ADM AS3MT C10orf26 CNNM2 CYP17A1-AS1 FMNL1 LRRC37A4P MAPT NT5C2 SMG6
Crohns Disease (2017)	1.46	4	1	2.2	0.38	6.2e-01	ADO GPX1 LOC441869 TMBIM1
Irritable Bowel Disease (IBD)	1.60	4	2	4.4	-0.35	6.5e-01	GPX1 LOC441869 TMBIM1 TNNI2
Ulcerative Colitis (UC)	1.46	4	2	4.4	-0.48	5.2e-01	GPX1 RGS19 TMBIM1 TNNI2
Major Depression (MDD)	1.66	2	0	0.0	0.00	1.0e+00	CNNM2 NT5C2
Reaction Time	1.83	4	2	4.4	-0.27	7.3e-01	ARL17A CAMK1G DLG4 SH2B3
Verbal and Numeric Reasoning (VNR)	1.48	5	3	6.7	-0.39	4.5e-01	CYP17A1-AS1 DCAF16 GPX1 MAPT SLC5A11
Breast Cancer	2.48	7	6	13.3	0.05	9.0e-01	FES LRRC37A4P LSP1 MAPT SLC4A7 SNX32 TNNT3
Ovarian Cancer	1.74	2	2	4.4	0.75	2.5e-01	LRRC37A4P MAPT
Prostate Cancer	1.47	1	0	0.0	0.00	1.0e+00	GPX1
Age at First Birth	1.55	2	1	2.2	0.00	1.0e+00	GPX1 TMEM110
Coronary Artery Disease (CAD)	3.10	3	1	2.2	0.00	1.0e+00	AS3MT CNNM2 RP1-257A7.5
Crohns Disease (2012)	1.50	1	0	0.0	0.00	1.0e+00	ADO
Fasting Glucose	1.41	1	0	0.0	0.00	1.0e+00	FNBP4
HDL Cholesterol	1.13	3	0	0.0	0.00	1.0e+00	ADRB1 SIPA1 SNX32
LDL Cholesterol	1.37	1	0	0.0	0.00	1.0e+00	SH2B3
Lupus	1.58	3	1	2.2	0.00	1.0e+00	FDFT1 PLEKHJ1 TCP11
Neuroticism (2016)	2.26	6	3	6.7	-0.21	6.3e-01	ADM FDFT1 FMNL1 GPX1 LRRC37A4P MAPT
Primary Biliary Cirrhosis	1.45	4	2	4.4	0.99	9.4e-04	FMNL1 IFT80 LRRC37A4P SH2B3
Rheumatoid Arthritis	1.39	2	0	0.0	0.00	1.0e+00	CDK6 SH2B3
Schizophrenia (2014)	2.32	9	7	15.6	0.58	1.0e-01	AS3MT C10orf26 CERS5 CNNM2 CYP17A1-AS1 FES MARK2 NT5C2 RERE
Triglycerides	0.91	1	0	0.0	0.00	1.0e+00	FDFT1
Ulcerative Colitis	1.38	3	1	2.2	0.00	1.0e+00	GPX1 TMBIM1 TNNI2
Blood Eosinophil Count	2.54	27	15	33.3	0.42	2.2e-02	AC074212.6 ACADVL CDK6 CERS5 CHP DCAKD DLG4 DULLARD FBXO38 FMNL1 FUT11 GATAD1 GPX1 LRRC37A4P MAPT MED19 NAT15 RERE SH2B3 SIPA1 SLC2A4 SNX32 TCP11 TMEM110 TRPV4 UPF3A ZNF831
Blood Platelet Count	1.61	40	28	62.2	0.32	4.2e-02	AC074212.6 ADO ARHGAP24 ARL17A BANP CDK6 CERS5 CFDP1 CLCN6 CRK CWF19L2 DCAF16 DCAKD DKFZp686O24166 DNAJC12 EDEM3 FNBP4 FUT11 GATAD1 GTF2B HDAC7 HELLS IPO11 IRAK1BP1 LACTB LIME1 MGRN1 MPP6 OCIAD1 RHOC RPS6KB1 SH2B3 SLC4A7 SMG6 SNX32 STXBP5 SZT2 TMBIM1 TRPV4 WNT2B
Blood Red Count	2.63	34	21	46.7	-0.16	3.6e-01	ADCY3 ADM C4orf22 CHP CLCN6 CNNM2 CRK DCAKD EIF2AK4 FMNL1 GATAD1 GTF2B HELLS HOXB9 LOC100129961 LRRC37A4P MAPT MGRN1 NME6 NOV NT5C2 RP11-332H18.4 RP11-541N10.3 RP1-257A7.5 RPS6KB1 SH2B3 SLC9A3R2 SNX32 SZT2 TMEM110 UBL7 UGT2B7 ULK4 USP36
Blood White Count	1.97	29	18	40.0	0.24	1.8e-01	ARHGAP24 CDK6 CERS5 CHP CRK DCAF16 DNAJC12 FBXO38 FES FMNL1 GLYR1 GPX1 HELLS HOXC8 INA LRRC37A4P MAPT NME6 NT5C2 RERE RP11-6N17.6 RPS6KB1 SH2B3 SLC5A11 SLC9A3R2 SZT2 TMBIM1 TMEM133 TNNI2
Heel T-Score	2.45	40	28	62.2	0.20	2.0e-01	ADCY3 ARHGAP24 ARL17A CDK6 CNNM2 COL21A1 CPEB2 DCAF16 DCAKD DLG4 DULLARD FMNL1 FNBP4 GATAD1 GTF2B IFT80 INA LRRC37A4P MAP1B MAPT NME6 NOV NT5C2 PLEKHM2 PUSL1 RERE RP11-6N17.6 SENP3 SGIP1 SIPA1 SLC5A11 SLC9A3R2 SMG6 SNX32 TCP11 TMBIM1 TMEM133 VGLL4 WNT2B ZNF827
BMI	1.70	28	18	40.0	0.06	7.5e-01	ADCY3 AS3MT ATP8B3 C10orf26 C4orf22 CLCN6 CNNM2 CYP17A1-AS1 DCAF12 DCAF16 DLG4 EDEM3 FAM108C1 FHL5 GPX1 LOC100129961 NT5C2 PLEKHM2 PMS2L3 RP11-296I10.6 RP5-890O3.9 RSRC1 SLC5A11 SLC9A3R2 SNX32 STXBP5 TMEM110 VGLL4
Height	2.57	69	56	124.4	-0.38	1.1e-03	AC074212.6 ADCY3 ADM ADO ADRB1 ARHGAP24 ARL17A AS3MT C10orf26 CDK6 CERS5 CFDP1 CHP CRK CYP17A1-AS1 DCAF12 DCAF16 DCAKD DKFZp686O24166 EDEM3 FES FGGY GATAD1 GLYR1 GOPC GPX1 GTF2B LRRC37A4P LSP1 MAPT MED19 MGRN1 MKLN1-AS2 MPP6 NME6 NOV OCIAD1 PMS2L3 PNPT1 PUSL1 RABL2A RERE RHOC RP11-296I10.6 RP11-332H18.4 RP11-6N17.6 RSRC1 SENP3 SH2B3 SLC16A1 SLC4A7 SLC5A11 SLC9A3R2 SMG6 SNX32 SZT2 TCP11 TEX2 TMBIM1 TMEM133 TNFSF12-TNFSF13 TNNT3 UBE2Z UBXN2A UPF3A USP36 WNT2B ZNF827 ZNF831
Waist Hip Ratio (WHR)	2.07	17	12	26.7	-0.17	4.8e-01	ADCY3 ADM DKFZp686O24166 FNBP4 GPX1 HOXC8 LRRC37A4P MAPT RGS19 RP11-332H18.4 SIPA1 SWAP70 TCEA2 TMBIM1 TMEM110 TNFSF12-TNFSF13 UBXN2A
Systolic Blood Pressure	15.75	151	139	308.9	0.98	1.0e-115	ABHD17C AC006111.1 AC074212.6 ACADVL ADAMTS8 ADCY3 ADM ADO ADRB1 AGT ARHGAP24 ARL17A AS3MT ATP2B1 ATP8B3 BANP C10orf26 C4orf22 CACNB2 CAMK1D CAMK1G CCDC148 CDK6 CEP68 CERS5 CFDP1 CHP CLCN6 CNNM2 COL21A1 CPEB2 CRK CWF19L2 CYP17A1-AS1 CYP46A1 DCAF12 DCAF16 DCAKD DKFZp686O24166 DLG4 DNAJC12 DULLARD EDEM3 EIF2AK4 EML1 FAM108C1 FBXO38 FES FGGY FHL5 FMNL1 FMNL3 FNBP4 FUT11 GATAD1 GLYR1 GOPC GPX1 GTF2B HDAC7 HELLS HOXA10 HOXB9 HOXC8 IFT80 IGFBP3 INA IPO11 IRAK1BP1 ITGB3 ITGB5 LACTB LIME1 LOC100129961 LOC441869 LRRC37A4P LSP1 MAP1B MAPT MARK2 MATN3 MED19 MGRN1 MKLN1-AS2 MPP6 NAT15 NME6 NOC3L NOV NPPA NSUN6 NT5C2 OCIAD1 PCGF6 PLEKHJ1 PLEKHM2 PMS2L3 PNPT1 PPP3CC PUSL1 RABL2A RBM23 RERE RGS19 RHOC RP11-296I10.6 RP11-332H18.4 RP11-421F16.3 RP11-541N10.3 RP11-588K22.2 RP11-6N17.6 RP1-257A7.5 RP5-890O3.9 RPS6KB1 RSRC1 SENP3 SGIP1 SH2B3 SIPA1 SLC16A1 SLC2A4 SLC4A7 SLC5A11 SLC9A3R2 SMG6 SNX24 SNX32 STXBP5 SWAP70 SZT2 TCEA2 TCP11 TEX2 TMBIM1 TMEM133 TNFSF12-TNFSF13 TNNI2 TNNT3 TRPV4 UBE2Z UBL7 UBXN2A UGT2B7 ULK4 UPF3A USP36 VGLL4 WNT2B ZBTB46 ZNF827 ZNF831
Smoking Status	1.88	11	5	11.1	-0.07	8.4e-01	AS3MT C10orf26 FES GPX1 INA MAPT NCAM1-AS1 NT5C2 RERE SLC5A11 SMG6
Allergy or Eczema	1.53	7	2	4.4	0.74	6.0e-02	CFDP1 CHP HDAC7 LIME1 PLEKHM2 RERE TMBIM1
Cardiovascular Disease	8.54	83	55	122.2	0.98	2.9e-56	AC006111.1 ADCY3 ADO ADRB1 AGT ARHGAP24 ARL17A AS3MT ATP2B1 ATP8B3 C10orf26 C4orf22 CACNB2 CCDC148 CDK6 CEP68 CERS5 CFDP1 CHP CLCN6 CNNM2 CPEB2 CRK CWF19L2 DCAF16 DCAKD DKFZp686O24166 DLG4 FAM108C1 FES FMNL3 FNBP4 FUT11 GATAD1 GLYR1 GOPC GTF2B HELLS HOXA10 HOXB9 HOXC8 IFT80 IRAK1BP1 ITGB3 ITGB5 LIME1 LSP1 MKLN1-AS2 NAT15 NME6 NOC3L NPPA NSUN6 NT5C2 PLEKHM2 PMS2L3 RGS19 RHOC RP11-296I10.6 RP11-332H18.4 RP11-588K22.2 SENP3 SGIP1 SH2B3 SIPA1 SLC2A4 SLC4A7 SNX32 SWAP70 TCEA2 TEX2 TMBIM1 TMEM133 TNFSF12-TNFSF13 TNNI2 TNNT3 UBE2Z UBL7 UPF3A USP36 VGLL4 ZBTB46 ZNF831
Hypothyroidism (self reported)	1.72	3	1	2.2	0.00	1.0e+00	PUSL1 RERE SH2B3
Respiratory disease	1.35	7	1	2.2	0.74	5.6e-02	AC074212.6 CHP DCAKD HDAC7 RERE TCP11 TNFSF12-TNFSF13
Type 2 Diabetes (T2D) (2018)	1.89	5	2	4.4	0.92	2.5e-02	CAMK1D DKFZp686O24166 SH2B3 SNX32 ZBTB46
Lung FEV1/FVC ratio	2.67	22	16	35.6	-0.24	2.8e-01	AC074212.6 ADM ADO ATP2B1 ATP8B3 CACNB2 CAMK1D CFDP1 CYP46A1 FBXO38 GOPC HOXC8 LACTB LRRC37A4P MAPT NOV RP11-6N17.6 TCP11 TMEM110 TMEM133 ULK4 VGLL4
Lung FVC	2.92	30	15	33.3	0.05	7.7e-01	ACADVL ADAMTS8 ARL17A CAMK1D CHP COL21A1 CRK DCAF16 DLG4 FBXO38 FMNL1 FMNL3 GPX1 HOXA10 HOXC8 LOC100129961 LRRC37A4P MAPT NAT15 NOV RP11-332H18.4 RP11-541N10.3 RP5-890O3.9 RSRC1 SLC2A4 SMG6 TCEA2 UBXN2A WNT2B ZBTB46
Neuroticism	2.74	9	7	15.6	0.11	7.5e-01	ADM AS3MT CNNM2 CYP17A1-AS1 FMNL1 GPX1 LRRC37A4P MAPT RERE
Chronotype (morning person)	1.03	1	0	0.0	0.00	1.0e+00	DCAF12
Hair Pigment	0.33	12	11	24.4	0.12	7.0e-01	ADM ARL17A ATP2B1 C4orf22 FES HOXB9 LOC100129961 RP11-6N17.6 SH2B3 SIPA1 SNX32 ZNF831
Tanning	0.27	3	1	2.2	0.00	1.0e+00	ADO RP11-6N17.6 SH2B3
Hand grip strength (left)	1.98	9	6	13.3	0.05	8.8e-01	C10orf26 DCAF16 LOC100129961 LRRC37A4P MAPT RP1-257A7.5 SLC5A11 SLC9A3R2 TNFSF12-TNFSF13
Number of treatments/medications taken	2.86	7	4	8.9	0.92	3.2e-03	FAM108C1 FES GPX1 SH2B3 TEX2 TMEM133 ZNF831
Sensitivity / hurt feelings	2.72	6	4	8.9	-0.94	6.3e-04	DCAKD FDFT1 FES FMNL1 LRRC37A4P MAPT
Frequency of depressed mood in last 2 weeks	1.45	1	0	0.0	0.00	1.0e+00	MAPT
Hearing difficulty/problems: Yes	1.50	2	0	0.0	0.00	1.0e+00	FUT11 SLC2A4
Relative age of first facial hair	2.86	7	6	13.3	-0.60	9.0e-02	C4orf22 DCAKD FMNL1 LRRC37A4P MAPT MKLN1-AS2 VGLL4
Angina	2.33	3	1	2.2	0.00	1.0e+00	FES RP1-257A7.5 TCEA2
Medication: Metformin	1.65	2	1	2.2	0.00	1.0e+00	CAMK1D DKFZp686O24166
Diabetes (mother)	1.51	2	1	2.2	0.00	1.0e+00	CAMK1D RP11-6N17.6
Pack years adult smoking proportion	1.16	1	0	0.0	0.00	1.0e+00	GPX1
Impedance of leg (right)	1.88	29	19	42.2	0.34	6.4e-02	ADM AS3MT C10orf26 CDK6 CERS5 CNNM2 DCAF12 DCAKD DKFZp686O24166 FAM108C1 FDFT1 FES FMNL1 GPX1 HELLS HOXC8 IGFBP3 LRRC37A4P MAPT NOC3L NT5C2 PMS2L3 RP5-890O3.9 RPS6KB1 SNX32 SWAP70 TMEM110 TMEM133 WNT2B
Leg fat-free mass (left)	1.99	27	18	40.0	-0.48	1.1e-02	ADM ADO ARHGAP24 AS3MT C10orf26 CDK6 CNNM2 CYP17A1-AS1 DCAF16 DCAKD FAM108C1 FDFT1 FES GATAD1 GLYR1 NOV NT5C2 PMS2L3 RP11-332H18.4 RP5-890O3.9 SLC5A11 SLC9A3R2 TCP11 TMEM110 TNFSF12-TNFSF13 UPF3A USP36
Trunk fat percentage	2.32	27	16	35.6	0.64	1.7e-04	ABHD17C ADM ARL17A CCDC148 DCAKD DLG4 EDEM3 FMNL1 FNBP4 GPX1 HELLS HOXA10 HOXC8 LOC100129961 LRRC37A4P MAPT MPP6 NOC3L OCIAD1 PMS2L3 RERE RP11-296I10.6 SENP3 SLC5A11 TNFSF12-TNFSF13 UPF3A WNT2B
Hand grip strength (right)	1.88	10	6	13.3	-0.11	7.4e-01	C10orf26 DCAF16 EDEM3 LOC100129961 LRRC37A4P MAPT RHOC SLC5A11 SLC9A3R2 TNFSF12-TNFSF13
Townsend deprivation index at recruitment	1.19	1	0	0.0	0.00	1.0e+00	SGIP1
Current tobacco smoking	1.58	2	0	0.0	0.00	1.0e+00	AS3MT SLC5A11
Average weekly fortified wine intake	1.20	1	0	0.0	0.00	1.0e+00	SLC5A11
Maternal smoking around birth	1.66	2	1	2.2	0.00	1.0e+00	AS3MT SLC5A11
Fed-up feelings	2.17	8	4	8.9	-0.35	3.3e-01	ACADVL FDFT1 FMNL1 GPX1 LRRC37A4P MAPT SH2B3 SLC5A11
Relative age voice broke	2.07	3	3	6.7	0.38	5.3e-01	FMNL1 LRRC37A4P MAPT
Taking other prescription medications	1.43	2	1	2.2	0.00	1.0e+00	GPX1 SH2B3
Age when periods started (menarche)	1.63	10	4	8.9	-0.63	5.1e-02	DCAKD GPX1 LRRC37A4P MAPT PMS2L3 SNX32 STXBP5 SZT2 TMEM110 TNNI2
Heel bone mineral density (BMD) T-score, automated (left)	2.02	9	7	15.6	0.59	9.8e-02	ARHGAP24 CDK6 FDFT1 GATAD1 MAPT RERE SIPA1 WNT2B ZNF827
High blood pressure	9.35	86	51	113.3	0.98	4.5e-60	AC006111.1 ADCY3 ADM ADO ADRB1 AGT ARHGAP24 ARL17A ATP2B1 ATP8B3 C4orf22 CACNB2 CCDC148 CERS5 CFDP1 CHP CLCN6 CNNM2 CWF19L2 DCAF12 DCAF16 DCAKD DKFZp686O24166 DLG4 DULLARD EDEM3 FAM108C1 FDFT1 FES FHL5 FMNL1 FNBP4 GLYR1 GOPC GTF2B HDAC7 HELLS HOXA10 HOXB9 HOXC8 IFT80 IRAK1BP1 ITGB5 LIME1 LRRC37A4P LSP1 MAPT MARK2 MGRN1 NAT15 NME6 NOC3L NPPA NSUN6 NT5C2 PLEKHJ1 PLEKHM2 PMS2L3 RGS19 RHOC RP11-296I10.6 RP11-332H18.4 RP11-588K22.2 RSRC1 SENP3 SGIP1 SH2B3 SIPA1 SLC2A4 SLC4A7 SLC5A11 SWAP70 TCEA2 TMEM133 TNFSF12-TNFSF13 TNNI2 TNNT3 U91328.21 UBE2Z UBL7 UGT2B7 UPF3A VGLL4 WNT2B ZBTB46 ZNF831
Hayfever, allergic rhinitis or eczema	1.40	2	2	4.4	0.00	1.0e+00	CHP RERE
Supplements: Glucosamine	1.36	1	0	0.0	0.00	1.0e+00	FBXO38
Medication: Atenolol	3.43	4	2	4.4	0.96	4.3e-02	FES RHOC SH2B3 TMEM133
Medication: Levothyroxine sodium	1.79	2	2	4.4	0.00	1.0e+00	PUSL1 SH2B3
Sitting height	2.10	28	21	46.7	-0.16	3.9e-01	AC074212.6 ADM ADRB1 CDK6 CERS5 CHP DCAF16 FAM108C1 GATAD1 GLYR1 GOPC GTF2B HELLS IGFBP3 LRRC37A4P MAPT NOV RSRC1 SLC4A7 SLC9A3R2 SZT2 TMBIM1 TNFSF12-TNFSF13 UBE2Z UBXN2A UPF3A VGLL4 ZNF831
High blood pressure (mother)	4.78	12	3	6.7	0.95	2.4e-06	AGT CFDP1 CLCN6 CNNM2 FES HOXA10 HOXC8 ITGB5 SLC4A7 TNNT3 UBE2Z ZNF831
Body mass index (BMI)	1.75	18	9	20.0	0.38	1.2e-01	AS3MT C10orf26 CCDC148 CLCN6 CNNM2 DCAF12 DCAF16 EDEM3 FDFT1 GPX1 LOC100129961 MPP6 PMS2L3 RP11-296I10.6 RP5-890O3.9 SLC5A11 SLC9A3R2 SNX32
Impedance of leg (left)	1.86	30	16	35.6	0.31	9.0e-02	ADM AS3MT C10orf26 CDK6 CERS5 CNNM2 DCAF12 DCAKD DKFZp686O24166 FAM108C1 FDFT1 FES FMNL1 GPX1 HELLS HOXC8 IGFBP3 LRRC37A4P MAPT NOC3L NT5C2 PMS2L3 RP11-296I10.6 RP5-890O3.9 RPS6KB1 SNX32 SWAP70 TMEM110 TMEM133 WNT2B
Leg predicted mass (left)	1.99	26	17	37.8	-0.46	1.9e-02	ADM ADO ARHGAP24 AS3MT C10orf26 CDK6 CNNM2 CYP17A1-AS1 DCAF16 DCAKD FAM108C1 FDFT1 GATAD1 GLYR1 NOV NT5C2 PMS2L3 RP11-332H18.4 RP5-890O3.9 SLC5A11 SLC9A3R2 TCP11 TMEM110 TNFSF12-TNFSF13 UPF3A USP36
Trunk fat mass	2.01	23	13	28.9	0.18	3.9e-01	ABHD17C ARL17A AS3MT C10orf26 CDK6 CNNM2 CYP17A1-AS1 DLG4 EDEM3 FNBP4 GPX1 HOXA10 LOC100129961 MAPT OCIAD1 PMS2L3 RERE RP11-296I10.6 SLC5A11 SLC9A3R2 SNX32 UPF3A WNT2B
Waist circumference	1.78	16	9	20.0	0.34	2.0e-01	ARL17A AS3MT CCDC148 CDK6 DLG4 DULLARD FAM108C1 FNBP4 HOXC8 PMS2L3 RP11-296I10.6 RP5-890O3.9 SLC2A4 SLC5A11 SLC9A3R2 SNX32
Number of incorrect matches in round	1.26	4	0	0.0	-0.15	8.5e-01	AS3MT CYP17A1-AS1 FES LOC100129961
Past tobacco smoking	1.61	4	1	2.2	-0.60	4.0e-01	AS3MT INA NT5C2 SH2B3
Alcohol usually taken with meals	1.34	2	0	0.0	0.00	1.0e+00	FES SZT2
Nervous feelings	2.36	10	7	15.6	0.26	4.2e-01	ADM AS3MT C10orf26 CNNM2 FBXO38 FDFT1 FMNL1 LRRC37A4P MAPT SMG6
Frequency of tenseness / restlessness in last 2 weeks	2.09	5	3	6.7	-0.06	8.9e-01	CNNM2 FMNL1 GPX1 LRRC37A4P MAPT
Hearing difficulty/problems with background noise	1.57	3	1	2.2	-1.00	1.4e-03	LRRC37A4P MAPT UBL7
Hair/balding pattern: Pattern 2	2.11	5	3	6.7	-1.00	5.4e-08	C4orf22 CPEB2 FMNL1 LRRC37A4P MAPT
Had menopause	1.16	1	0	0.0	0.00	1.0e+00	CHP
Forced vital capacity (FVC)	3.05	22	15	33.3	-0.37	7.2e-02	ADCY3 ARL17A CAMK1D CDK6 DCAF16 DULLARD FMNL1 FMNL3 GPX1 LOC100129961 LRRC37A4P MAPT NOV RHOC RP11-541N10.3 RP11-6N17.6 RSRC1 SLC2A4 TCP11 TMBIM1 U91328.21 UPF3A
Heel bone mineral density (BMD) T-score, automated (right)	2.10	9	7	15.6	0.56	1.2e-01	ARHGAP24 CDK6 FDFT1 GATAD1 MAPT RERE SIPA1 WNT2B ZNF827
Ever unenthusiastic/disinterested for a whole week	1.51	2	0	0.0	0.00	1.0e+00	LRRC37A4P MAPT
Qualifications: None of the above	1.63	5	3	6.7	0.99	1.6e-03	GPX1 IRAK1BP1 MPP6 SLC5A11 UBE2Z
Mouth/teeth dental problems	1.46	1	0	0.0	0.00	1.0e+00	MAPT
Heart attack	2.42	3	2	4.4	0.00	1.0e+00	FES NME6 RP1-257A7.5
Allergy	1.33	6	2	4.4	-0.52	2.9e-01	CHP FES HDAC7 LIME1 RERE TMBIM1
Diabetes (self-reported)	1.59	3	1	2.2	0.00	1.0e+00	CAMK1D DKFZp686O24166 ZBTB46
Medication: Ramipril	3.09	5	1	2.2	0.63	2.5e-01	FES GOPC LSP1 TMEM133 UBL7
Medication: Simvastatin	2.34	3	2	4.4	0.00	1.0e+00	FES TCEA2 ZNF831
Fluid intelligence score	1.47	2	1	2.2	0.00	1.0e+00	DCAF16 MAPT
Illnesses of siblings	3.09	6	1	2.2	-0.99	4.8e-05	CLCN6 FES LOC441869 NME6 SH2B3 SLC5A11
Neuroticism score	2.66	7	5	11.1	-0.40	2.9e-01	ADM FBXO38 FDFT1 FMNL1 GPX1 LRRC37A4P MAPT
Weight	1.82	25	18	40.0	-0.15	4.7e-01	AS3MT C10orf26 CDK6 CNNM2 CYP17A1-AS1 DCAF16 DLG4 FAM108C1 FDFT1 GATAD1 GLYR1 GPX1 OCIAD1 PMS2L3 RP11-296I10.6 RP11-332H18.4 RP5-890O3.9 SH2B3 SLC5A11 SLC9A3R2 SNX32 TCP11 UPF3A USP36 WNT2B
Impedance of arm (right)	2.30	29	20	44.4	0.07	7.0e-01	ADAMTS8 ADM ARL17A CERS5 DCAF12 DCAKD DKFZp686O24166 EML1 FDFT1 FMNL1 GPX1 HELLS HOXA10 HOXC8 LIME1 LRRC37A4P LSP1 MAPT NOC3L PMS2L3 RP5-890O3.9 RPS6KB1 SENP3 SLC4A7 SLC9A3R2 SNX32 TMEM110 TNFSF12-TNFSF13 WNT2B
Arm fat percentage (right)	2.12	28	10	22.2	0.58	1.2e-03	ABHD17C ADM ARL17A CCDC148 CLCN6 CNNM2 DCAF16 DLG4 DULLARD EDEM3 FDFT1 FNBP4 GPX1 HOXA10 HOXC8 LOC100129961 MPP6 NOV PMS2L3 RERE RP11-296I10.6 SENP3 SLC2A4 SLC5A11 SMG6 SNX32 STXBP5 TNFSF12-TNFSF13
Trunk fat-free mass	2.49	35	21	46.7	-0.53	1.1e-03	ADCY3 ADM ADO ARHGAP24 AS3MT C10orf26 CDK6 CHP CNNM2 CYP17A1-AS1 DCAF16 DCAKD FAM108C1 FMNL1 GATAD1 GLYR1 HELLS LIME1 NOV OCIAD1 PUSL1 RP11-332H18.4 RP5-890O3.9 SENP3 SH2B3 SLC4A7 SLC5A11 SLC9A3R2 TCP11 TMBIM1 TMEM110 TNFSF12-TNFSF13 UBE2Z UPF3A USP36
Hip circumference	1.83	19	10	22.2	-0.22	3.5e-01	AS3MT C10orf26 CDK6 CLCN6 CNNM2 CYP17A1-AS1 DLG4 FAM108C1 FDFT1 GPX1 LOC100129961 NPPA PMS2L3 RP11-296I10.6 RP5-890O3.9 SH2B3 SLC5A11 SLC9A3R2 UPF3A
Father's age at death	1.65	3	2	4.4	0.00	1.0e+00	FES GPX1 SH2B3
Worrier / anxious feelings	2.19	8	7	15.6	0.23	5.3e-01	AS3MT C10orf26 CNNM2 CYP17A1-AS1 FDFT1 FMNL1 LRRC37A4P MAPT
Frequency of tiredness / lethargy in last 2 weeks	1.38	2	0	0.0	0.00	1.0e+00	GPX1 PPP3CC
Hair/balding pattern: Pattern 3	3.00	5	4	8.9	0.97	3.7e-04	C4orf22 DCAKD FMNL1 LRRC37A4P MAPT
Number of live births	1.59	2	0	0.0	-0.11	8.9e-01	LRRC37A4P MAPT
Forced expiratory volume in 1-second (FEV1)	3.14	22	15	33.3	-0.24	2.6e-01	ADCY3 ARL17A CAMK1D CDK6 DCAF16 FBXO38 FDFT1 FMNL1 GOPC GPX1 LOC100129961 LRRC37A4P MAPT NOV RHOC RP11-541N10.3 RSRC1 TCP11 TMBIM1 TMEM133 U91328.21 UPF3A
Pulse rate	1.46	1	1	2.2	0.00	1.0e+00	RBM23
Noisy workplace	1.39	1	0	0.0	0.00	1.0e+00	MAPT
Qualifications: A levels/AS levels or equivalent	1.65	5	2	4.4	-0.45	3.7e-01	GPX1 MAPT MPP6 PMS2L3 SLC5A11
Mouth/teeth dental problems: Dentures	1.45	4	0	0.0	0.33	6.7e-01	GPX1 HOXB9 RP11-6N17.6 RPS6KB1
Asthma	1.35	3	1	2.2	0.00	1.0e+00	AC074212.6 RERE TCP11
Medication: Ibuprofen (e.g. Nurofen)	1.89	4	1	2.2	-0.82	1.8e-01	FMNL1 LRRC37A4P MAPT RP1-257A7.5
Medication: Cholesterol lowering	2.28	5	2	4.4	0.94	1.7e-02	CLCN6 FES TCEA2 TMEM133 ZNF831
Illnesses of mother	2.97	2	1	2.2	0.00	1.0e+00	FES UBE2Z
Forced expiratory volume in 1-second (FEV1), Best measure	3.01	18	11	24.4	-0.29	2.2e-01	ADCY3 ADO ARL17A CAMK1D CDK6 DCAF16 FBXO38 FDFT1 FMNL1 FMNL3 GPX1 LOC100129961 LRRC37A4P MAPT RSRC1 TCP11 U91328.21 UPF3A
Impedance of arm (left)	2.31	31	21	46.7	0.05	7.7e-01	ADAMTS8 ADM ARL17A CERS5 DCAF12 DCAKD DKFZp686O24166 FAM108C1 FDFT1 FMNL1 GPX1 HELLS HOXA10 HOXC8 LIME1 LRRC37A4P LSP1 MAPT NOC3L PMS2L3 RP5-890O3.9 RPS6KB1 SENP3 SH2B3 SLC4A7 SLC9A3R2 SNX32 TMEM110 TNFSF12-TNFSF13 TNNT3 WNT2B
Arm fat mass (right)	1.77	22	8	17.8	0.15	5.2e-01	ABHD17C ARL17A AS3MT C10orf26 CDK6 CLCN6 CNNM2 CYP17A1-AS1 DLG4 EDEM3 FDFT1 FNBP4 GPX1 HOXA10 LOC100129961 PMS2L3 RP11-296I10.6 RP5-890O3.9 SLC5A11 SLC9A3R2 SNX32 STXBP5
Trunk predicted mass	2.48	34	21	46.7	-0.56	6.1e-04	ADCY3 ADM ADO ARHGAP24 AS3MT C10orf26 CDK6 CHP CNNM2 CYP17A1-AS1 DCAF16 DCAKD FAM108C1 FMNL1 GATAD1 GLYR1 HELLS LIME1 NOV PUSL1 RP11-332H18.4 RP5-890O3.9 SENP3 SH2B3 SLC4A7 SLC5A11 SLC9A3R2 TCP11 TMBIM1 TMEM110 TNFSF12-TNFSF13 UBE2Z UPF3A USP36
Standing height	2.47	49	38	84.4	-0.35	1.3e-02	AC074212.6 ADCY3 ADM ADO ADRB1 ARHGAP24 ARL17A AS3MT C10orf26 CDK6 CERS5 CFDP1 CHP CYP17A1-AS1 DCAF16 DCAKD DKFZp686O24166 EDEM3 FDFT1 GATAD1 GLYR1 GOPC GPX1 GTF2B LRRC37A4P LSP1 MAPT MGRN1 MPP6 NOV OCIAD1 PPP3CC RHOC RP11-296I10.6 RP11-332H18.4 RP11-6N17.6 SH2B3 SLC4A7 SLC5A11 SLC9A3R2 TCP11 TMBIM1 TNFSF12-TNFSF13 U91328.21 UBE2Z UPF3A USP36 WNT2B ZNF831
Breastfed as a baby	1.52	3	1	2.2	0.00	1.0e+00	LOC441869 PUSL1 RP5-890O3.9
Tense / 'highly strung'	1.74	4	0	0.0	0.04	9.6e-01	CNNM2 FDFT1 MAPT NT5C2
Seen doctor (GP) for nerves, anxiety, tension or depression	1.41	1	0	0.0	0.00	1.0e+00	SGIP1
Hair/balding pattern: Pattern 4	4.19	8	6	13.3	0.69	2.6e-02	C4orf22 CERS5 DCAKD FMNL1 LRRC37A4P MAPT MKLN1-AS2 SMG6
Birth weight of first child	3.17	10	5	11.1	-0.75	7.9e-03	ACADVL AS3MT CFDP1 CLCN6 DCAF16 DLG4 FES GTF2B PMS2L3 SH2B3
Peak expiratory flow (PEF)	2.50	15	7	15.6	-0.38	1.3e-01	ACADVL CAMK1D CFDP1 DCAF16 DLG4 DULLARD FBXO38 FDFT1 LOC441869 LRRC37A4P MAPT PUSL1 SLC2A4 SLC9A3R2 TCP11
Pulse wave reflection index	1.62	1	0	0.0	0.00	1.0e+00	ADAMTS8
Qualifications: O levels/GCSEs or equivalent	1.61	3	1	2.2	0.00	1.0e+00	GPX1 MPP6 RPS6KB1
Medication: Paracetamol	2.65	5	5	11.1	0.10	8.3e-01	FHL5 GPX1 LRRC37A4P MAPT RP1-257A7.5
Headache pain in last month	2.79	8	5	11.1	-0.15	6.8e-01	AC074212.6 CFDP1 FHL5 FMNL1 LRRC37A4P MAPT MED19 RP1-257A7.5
Medication for cholesterol, blood pressure or diabetes	4.45	17	9	20.0	-0.98	4.0e-12	ATP2B1 C4orf22 CAMK1D CLCN6 FAM108C1 FES NME6 RGS19 RHOC SH2B3 SLC4A7 TCEA2 TMEM133 UBL7 UPF3A ZBTB46 ZNF831
Gout (self-reported)	1.48	3	0	0.0	0.00	1.0e+00	SH2B3 SIPA1 U91328.21
Hypothyroidism/myxoedema (self-reported)	1.71	4	1	2.2	0.64	3.6e-01	FDFT1 PUSL1 RERE SH2B3
Medication: Amlodipine	4.49	12	6	13.3	0.95	1.4e-06	CLCN6 FAM108C1 FES GLYR1 LSP1 RHOC SENP3 SIPA1 TMEM133 TNFSF12-TNFSF13 TNNI2 TNNT3
Birth weight	3.74	12	9	20.0	0.01	9.8e-01	ACADVL ADRB1 AS3MT CDK6 CNNM2 DCAF16 DLG4 DULLARD FES SH2B3 SLC2A4 SMG6
High blood pressure (siblings)	4.14	9	2	4.4	0.98	7.4e-07	ADO CLCN6 FES NPPA RHOC SGIP1 SH2B3 TMEM133 TNNT3
Forced vital capacity (FVC), Best measure	2.89	19	13	28.9	-0.36	1.1e-01	ADCY3 ARL17A CAMK1D CDK6 DCAF16 FMNL1 FMNL3 GPX1 LOC100129961 LRRC37A4P MAPT NOV RHOC RP11-6N17.6 RSRC1 TCP11 TMBIM1 U91328.21 UPF3A
Body fat percentage	2.27	30	14	31.1	0.63	1.7e-04	ABHD17C ADM ARL17A CCDC148 CLCN6 DCAF16 DCAKD DLG4 EDEM3 FMNL1 FNBP4 GPX1 HELLS HOXA10 HOXC8 LOC100129961 MPP6 NOC3L NOV PMS2L3 RERE RP11-296I10.6 RP1-257A7.5 SENP3 SLC5A11 SLC9A3R2 SNX32 STXBP5 TNFSF12-TNFSF13 WNT2B
Leg fat percentage (right)	2.20	24	12	26.7	0.81	1.4e-06	ABHD17C ADM CCDC148 CHP CLCN6 CRK DCAF16 DLG4 EDEM3 GPX1 GTF2B HELLS LOC100129961 MPP6 NOC3L NOV PMS2L3 RERE RP11-296I10.6 SLC5A11 SLC9A3R2 SNX32 STXBP5 WNT2B
Arm fat-free mass (right)	2.20	31	17	37.8	-0.49	5.0e-03	ADM ARHGAP24 AS3MT C10orf26 CDK6 CNNM2 CYP17A1-AS1 DCAF16 DCAKD FAM108C1 FDFT1 FMNL1 GATAD1 GLYR1 GPX1 LIME1 NOV RP11-332H18.4 RP5-890O3.9 SENP3 SH2B3 SLC5A11 SLC9A3R2 SNX32 TCP11 TMBIM1 TMEM110 TNFSF12-TNFSF13 TRPV4 UPF3A USP36
Comparative body size at age 10	1.56	9	4	8.9	-0.31	4.2e-01	ADCY3 CAMK1G CERS5 FDFT1 RP5-890O3.9 SIPA1 SMG6 VGLL4 WNT2B
Worry too long after embarrassment	1.76	3	1	2.2	-0.84	7.4e-02	FDFT1 LRRC37A4P MAPT
Seen a psychiatrist for nerves, anxiety, tension or depression	1.37	1	0	0.0	0.00	1.0e+00	ADRB1
Wheeze or whistling in the chest in last year	1.30	1	0	0.0	0.00	1.0e+00	AC074212.6
Age at first live birth	1.52	1	1	2.2	0.00	1.0e+00	GPX1
Shortness of breath walking on level ground	1.26	1	0	0.0	0.00	1.0e+00	SGIP1
Qualifications: College or University degree	1.73	10	4	8.9	-0.33	3.0e-01	CCDC148 DCAF16 EDEM3 GPX1 GTF2B LRRC37A4P MAPT MPP6 PMS2L3 SLC5A11
Medication for pain relief, constipation, heartburn	2.19	6	4	8.9	-0.31	4.5e-01	FAM108C1 FHL5 GPX1 LRRC37A4P MAPT RP1-257A7.5
Neck or shoulder pain in last month	1.32	1	0	0.0	0.00	1.0e+00	GPX1
Medication: Blood pressure	5.90	27	16	35.6	0.98	5.0e-19	ADRB1 ATP2B1 C4orf22 CLCN6 CWF19L2 DLG4 DULLARD FAM108C1 FES FNBP4 HOXA10 LSP1 NME6 NOC3L NPPA RHOC SENP3 SH2B3 SLC2A4 SLC4A7 TMEM133 TNNI2 TNNT3 UBL7 UPF3A ZBTB46 ZNF831
Angina (self-reported)	2.38	3	1	2.2	0.00	1.0e+00	FES RP1-257A7.5 TCEA2
Migraine (self-reported)	2.00	3	2	4.4	0.00	1.0e+00	FHL5 NT5C2 RP1-257A7.5
Medication: Ibuprofen	1.75	1	0	0.0	0.00	1.0e+00	RP1-257A7.5
Mean time to correctly identify matches	1.77	5	2	4.4	0.33	5.9e-01	ACADVL ARL17A DLG4 DULLARD SH2B3
Whole body fat mass	1.90	26	11	24.4	0.28	1.7e-01	ABHD17C ARL17A AS3MT C10orf26 CCDC148 CDK6 CNNM2 CYP17A1-AS1 DLG4 EDEM3 FAM108C1 FDFT1 FNBP4 GPX1 HOXA10 LOC100129961 OCIAD1 PMS2L3 RERE RP11-296I10.6 SLC5A11 SLC9A3R2 SNX32 STXBP5 UPF3A WNT2B
Leg fat mass (right)	1.87	18	8	17.8	0.31	2.2e-01	ABHD17C AS3MT C10orf26 CDK6 CNNM2 EDEM3 FDFT1 GPX1 LOC100129961 MPP6 PMS2L3 RP11-296I10.6 RP5-890O3.9 SLC5A11 SLC9A3R2 SNX32 STXBP5 WNT2B
Arm predicted mass (right)	2.25	31	16	35.6	-0.46	9.8e-03	ADM ARHGAP24 AS3MT C10orf26 CDK6 CNNM2 CYP17A1-AS1 DCAF16 DCAKD FAM108C1 FDFT1 FMNL1 GATAD1 GLYR1 GPX1 LIME1 NOV PMS2L3 RP11-332H18.4 RP5-890O3.9 SENP3 SH2B3 SLC5A11 SLC9A3R2 SNX32 TCP11 TMBIM1 TMEM110 TNFSF12-TNFSF13 UPF3A USP36
Pulse rate, automated reading	1.61	7	3	6.7	-0.29	5.3e-01	FNBP4 LOC100129961 MKLN1-AS2 PMS2L3 RBM23 SZT2 TMEM110
Alcohol intake frequency.	1.58	5	2	4.4	-0.43	3.3e-01	FNBP4 LRRC37A4P MAPT RP1-257A7.5 RPS6KB1
Comparative height size at age 10	2.24	26	18	40.0	-0.29	1.4e-01	ADCY3 CDK6 CFDP1 DCAF16 DKFZp686O24166 FAM108C1 GATAD1 GLYR1 GPX1 GTF2B IGFBP3 LRRC37A4P MAPT NOV OCIAD1 RP11-332H18.4 RP11-6N17.6 SH2B3 SLC9A3R2 SZT2 TCP11 TMBIM1 U91328.21 UBE2Z UPF3A WNT2B
Suffer from 'nerves'	1.77	4	0	0.0	0.38	6.2e-01	AS3MT FDFT1 MAPT SMG6
Overall health rating	1.71	5	2	4.4	0.96	8.7e-03	CEP68 DCAKD GPX1 SLC5A11 SNX32
Age at last live birth	1.42	1	1	2.2	0.00	1.0e+00	GPX1
Medication: Aspirin	2.33	2	1	2.2	0.00	1.0e+00	FES GOPC
Hypertension (Self-reported)	9.17	81	52	115.6	0.98	2.8e-56	AC006111.1 ADCY3 ADM ADO ADRB1 AGT ARHGAP24 ARL17A ATP2B1 ATP8B3 C4orf22 CACNB2 CCDC148 CERS5 CFDP1 CHP CLCN6 CNNM2 CWF19L2 DCAF12 DCAF16 DCAKD DKFZp686O24166 DLG4 DULLARD EDEM3 FAM108C1 FDFT1 FES FHL5 FMNL1 FNBP4 GLYR1 GOPC GTF2B HDAC7 HELLS HOXA10 HOXB9 HOXC8 IRAK1BP1 ITGB5 LIME1 LRRC37A4P LSP1 MARK2 MGRN1 NAT15 NME6 NOC3L NPPA NSUN6 NT5C2 PLEKHM2 PMS2L3 RGS19 RHOC RP11-296I10.6 RP11-332H18.4 RP11-588K22.2 RSRC1 SENP3 SH2B3 SIPA1 SLC2A4 SLC4A7 SLC5A11 SWAP70 TCEA2 TMEM133 TNFSF12-TNFSF13 TNNI2 TNNT3 U91328.21 UBE2Z UBL7 UPF3A VGLL4 WNT2B ZBTB46 ZNF831
Gastro-oesophageal reflux (gord) / gastric reflux (Self-reported)	1.46	2	0	0.0	0.00	1.0e+00	FMNL1 MARK2
Illnesses of father: Heart disease	2.43	2	2	4.4	0.00	1.0e+00	FES RP1-257A7.5
Illnesses of siblings: Diabetes	1.57	1	1	2.2	0.00	1.0e+00	CAMK1D
Smoking status: Previous	1.27	1	0	0.0	0.00	1.0e+00	SH2B3
Forced expiratory volume in 1-second (FEV1), predicted	2.00	4	3	6.7	-0.97	2.7e-02	CDK6 CYP17A1-AS1 DCAF16 TCP11
Whole body fat-free mass	2.30	31	21	46.7	-0.52	3.0e-03	ADM ADO ARHGAP24 AS3MT C10orf26 CDK6 CNNM2 CYP17A1-AS1 DCAF16 DCAKD FAM108C1 FDFT1 FMNL1 GATAD1 GLYR1 HELLS NOV NT5C2 PMS2L3 RP11-332H18.4 RP5-890O3.9 SH2B3 SLC4A7 SLC5A11 SLC9A3R2 TCP11 TMBIM1 TMEM110 TNFSF12-TNFSF13 UPF3A USP36
Leg fat-free mass (right)	2.02	27	19	42.2	-0.53	4.3e-03	ADM ADO ARHGAP24 AS3MT C10orf26 CDK6 CNNM2 CYP17A1-AS1 DCAF16 DCAKD FAM108C1 FDFT1 FES GATAD1 GLYR1 HELLS NOV NT5C2 PMS2L3 RP11-332H18.4 RP5-890O3.9 SLC5A11 SLC9A3R2 TCP11 TMEM110 TNFSF12-TNFSF13 UPF3A
Arm fat percentage (left)	2.09	27	10	22.2	0.65	2.3e-04	ABHD17C ADM ARL17A CCDC148 CHP CNNM2 DCAF16 DLG4 EDEM3 FDFT1 FNBP4 GPX1 HOXA10 HOXC8 LOC100129961 MPP6 NOV PMS2L3 RERE RP11-296I10.6 RP1-257A7.5 SENP3 SLC2A4 SLC5A11 SNX32 STXBP5 TNFSF12-TNFSF13
Handedness (chirality/laterality): Left-handed	1.81	2	2	4.4	0.38	6.2e-01	LRRC37A4P MAPT
Mood swings	2.26	5	4	8.9	-0.03	9.5e-01	FMNL1 GPX1 LRRC37A4P MAPT SLC5A11
Loneliness, isolation	1.87	2	1	2.2	0.00	1.0e+00	GPX1 MAPT
Diabetes diagnosed by doctor	1.70	3	3	6.7	0.00	1.0e+00	CAMK1D DKFZp686O24166 ZBTB46
Mouth/teeth dental problems: Mouth ulcers	1.85	4	3	6.7	-0.76	7.8e-02	IFT80 ITGB3 LRRC37A4P MAPT
Medication for cholesterol	4.76	15	6	13.3	-0.96	2.1e-08	C4orf22 FES HOXA10 HOXC8 LIME1 LRRC37A4P LSP1 MGRN1 RHOC SH2B3 TMEM133 TNNT3 WNT2B ZBTB46 ZNF831
Breast cancer (self-reported)	1.26	1	0	0.0	0.00	1.0e+00	SLC4A7
Asthma (self-reported)	1.28	4	1	2.2	0.98	1.6e-02	AC074212.6 HDAC7 RERE TCP11
Medication: Aspirin	2.26	1	1	2.2	0.00	1.0e+00	FES
Medication: Gliclazide	1.52	1	0	0.0	0.00	1.0e+00	DKFZp686O24166
Illnesses of father: None of the above (group 1)	2.84	3	1	2.2	0.00	1.0e+00	CYP17A1-AS1 FES SH2B3
Smoking status: Current	1.65	2	0	0.0	0.00	1.0e+00	AS3MT SMG6
Forced expiratory volume in 1-second (FEV1), predicted percentage	2.34	9	7	15.6	-0.20	5.6e-01	CAMK1D CFDP1 FBXO38 FDFT1 FMNL1 LRRC37A4P MAPT RP11-541N10.3 TCP11
Whole body water mass	2.29	31	21	46.7	-0.55	1.4e-03	ADM ADO ARHGAP24 AS3MT C10orf26 CDK6 CNNM2 CYP17A1-AS1 DCAF16 DCAKD FAM108C1 FDFT1 FMNL1 GATAD1 GLYR1 HELLS NOV NT5C2 PMS2L3 RP11-332H18.4 RP5-890O3.9 SH2B3 SLC5A11 SLC9A3R2 TCP11 TMBIM1 TMEM110 TNFSF12-TNFSF13 UBE2Z UPF3A USP36
Leg predicted mass (right)	2.03	27	19	42.2	-0.53	4.2e-03	ADM ADO ARHGAP24 AS3MT C10orf26 CDK6 CNNM2 CYP17A1-AS1 DCAF16 DCAKD FAM108C1 FDFT1 FES GATAD1 GLYR1 HELLS NOV NT5C2 PMS2L3 RP11-332H18.4 RP5-890O3.9 SLC5A11 SLC9A3R2 TCP11 TMEM110 TNFSF12-TNFSF13 UPF3A
Arm fat mass (left)	1.74	20	10	22.2	0.25	3.0e-01	ABHD17C ARL17A AS3MT C10orf26 CCDC148 CDK6 CNNM2 CYP17A1-AS1 DLG4 FDFT1 FNBP4 GPX1 LOC100129961 PMS2L3 RP11-296I10.6 RP5-890O3.9 SLC5A11 SLC9A3R2 SNX32 STXBP5
Number of self-reported non-cancer illnesses	2.87	5	3	6.7	0.94	1.9e-02	CLCN6 HDAC7 SH2B3 TCEA2 ZNF831
Average weekly champagne plus white wine intake	1.70	2	0	0.0	-0.42	5.8e-01	LRRC37A4P MAPT
Miserableness	1.84	5	3	6.7	0.04	9.3e-01	FDFT1 FNBP4 GPX1 LRRC37A4P MAPT
Guilty feelings	1.97	5	1	2.2	0.11	8.1e-01	FDFT1 FNBP4 LRRC37A4P MAPT UBXN2A
Financial situation satisfaction	1.18	1	1	2.2	0.00	1.0e+00	GPX1
Medication: Blood pressure	7.78	42	30	66.7	0.97	1.4e-28	ADCY3 ADM ADRB1 AGT C4orf22 CACNB2 CERS5 CHP CLCN6 CNNM2 CWF19L2 DLG4 FAM108C1 FDFT1 FES FMNL1 GTF2B HOXA10 HOXC8 LIME1 LRRC37A4P LSP1 MAPT MGRN1 NPPA NSUN6 NT5C2 RHOC RP11-588K22.2 SENP3 SH2B3 SIPA1 SLC4A7 TCEA2 TMEM133 TNFSF12-TNFSF13 TNNI2 TNNT3 UBL7 WNT2B ZBTB46 ZNF831
Supplements: Fish oil (including cod liver oil)	1.13	1	0	0.0	0.00	1.0e+00	DCAKD
High cholesterol (Self-reported)	2.12	5	2	4.4	0.90	3.8e-02	CLCN6 RGS19 TCEA2 TMBIM1 TMEM133
Medication: Bendroflumethiazide	5.14	18	9	20.0	0.94	4.9e-09	ADRB1 AGT ATP2B1 CACNB2 CLCN6 FES FNBP4 HOXA10 LSP1 MGRN1 RHOC SLC4A7 TMEM133 TNFSF12-TNFSF13 TNNI2 TNNT3 UBL7 ZNF831
Medication: Paracetamol	2.53	4	2	4.4	0.02	9.7e-01	FHL5 GPX1 LRRC37A4P MAPT
Medication: Lisinopril	3.23	3	0	0.0	0.00	1.0e+00	ADO LSP1 ZNF831
Illnesses of father: High blood pressure	3.39	4	1	2.2	0.99	6.4e-03	ADCY3 C4orf22 FES UPF3A
Ever smoked	1.54	1	0	0.0	0.00	1.0e+00	AS3MT
Basal metabolic rate	2.14	31	21	46.7	-0.40	2.5e-02	ADM ADO ARHGAP24 AS3MT C10orf26 CDK6 CNNM2 CYP17A1-AS1 DCAF16 DCAKD FAM108C1 FDFT1 GATAD1 GLYR1 GPX1 NOV NT5C2 OCIAD1 PMS2L3 RP11-332H18.4 RP5-890O3.9 SH2B3 SLC5A11 SLC9A3R2 SNX32 TCP11 TMBIM1 TMEM110 TNFSF12-TNFSF13 UPF3A USP36
Leg fat percentage (left)	2.14	21	11	24.4	0.72	2.6e-04	ABHD17C ADM CCDC148 CLCN6 CRK DCAF16 EDEM3 GPX1 GTF2B HELLS LOC100129961 MPP6 NOV PMS2L3 RERE RP11-296I10.6 RP5-890O3.9 SLC5A11 SLC9A3R2 SNX32 WNT2B
Arm fat-free mass (left)	2.22	32	18	40.0	-0.42	1.8e-02	ADM ARHGAP24 AS3MT C10orf26 CDK6 CNNM2 CYP17A1-AS1 DCAF16 DCAKD FAM108C1 FDFT1 FMNL1 GATAD1 GLYR1 GPX1 LIME1 NOV OCIAD1 PMS2L3 RP11-332H18.4 RP5-890O3.9 SENP3 SH2B3 SLC5A11 SLC9A3R2 SNX32 TCP11 TMBIM1 TMEM110 TNFSF12-TNFSF13 UPF3A USP36
Average weekly beer plus cider intake	1.21	1	0	0.0	0.00	1.0e+00	FDFT1
Irritability	1.98	4	3	6.7	-0.49	3.2e-01	FDFT1 GPX1 LRRC37A4P MAPT
Diastolic blood pressure, automated reading	8.58	88	62	137.8	0.89	3.3e-32	AC006111.1 ACADVL ADAMTS8 ADCY3 ADM ADO ADRB1 AGT ARHGAP24 ARL17A ATP2B1 C4orf22 CACNB2 CCDC148 CERS5 CHP CLCN6 CNNM2 CWF19L2 DCAF12 DCAF16 DCAKD DLG4 DNAJC12 DULLARD EDEM3 EIF2AK4 FAM108C1 FDFT1 FES FMNL1 FNBP4 GPX1 HDAC7 HELLS HOXA10 IGFBP3 INA IPO11 IRAK1BP1 ITGB5 LIME1 LOC100129961 LSP1 MED19 MKLN1-AS2 MPP6 NAT15 NCAM1-AS1 NME6 NOC3L NOV NPPA NSUN6 NT5C2 PMS2L3 RABL2A RERE RGS19 RHOC RP11-332H18.4 RSRC1 SENP3 SH2B3 SIPA1 SLC16A1 SLC2A4 SLC5A11 SLC9A3R2 SMG6 SNX32 STXBP5 SWAP70 SZT2 TCEA2 TCP11 TEX2 TMEM133 TNNI2 TNNT3 TRPV4 UBE2Z UBL7 ULK4 UPF3A USP36 WNT2B ZNF831
Unable to work because of sickness or disability	1.20	1	0	0.0	0.00	1.0e+00	SLC5A11
Vascular/heart problems diagnosed by doctor	8.85	74	44	97.8	-0.98	6.3e-53	AC006111.1 ADCY3 ADO ADRB1 AGT ARHGAP24 ATP2B1 C4orf22 CACNB2 CCDC148 CEP68 CERS5 CFDP1 CHP CLCN6 CNNM2 CWF19L2 DCAF16 DCAKD DLG4 EDEM3 FAM108C1 FDFT1 FES FMNL1 FNBP4 GLYR1 GOPC GTF2B HDAC7 HOXA10 HOXB9 HOXC8 INA IRAK1BP1 ITGB5 LIME1 LSP1 MARK2 MGRN1 NAT15 NME6 NOC3L NPPA NSUN6 NT5C2 PLEKHM2 RGS19 RHOC RP11-588K22.2 RSRC1 SENP3 SGIP1 SH2B3 SIPA1 SLC2A4 SLC4A7 SLC5A11 SNX32 SWAP70 SZT2 TCEA2 TEX2 TMEM133 TNFSF12-TNFSF13 TNNI2 TNNT3 UBE2Z UBL7 UGT2B7 VGLL4 WNT2B ZBTB46 ZNF831
Cholesterol lowering medication	2.22	3	0	0.0	0.00	1.0e+00	MARK2 TCEA2 UGT2B7
Pain experienced in last month	1.49	3	1	2.2	0.00	1.0e+00	FHL5 GPX1 MAPT
Heart attack/myocardial infarction (self-reported)	2.35	4	2	4.4	0.53	4.7e-01	FES NME6 RP1-257A7.5 SH2B3
Heart disease (siblings)	2.18	1	0	0.0	0.00	1.0e+00	FES
Pack years of smoking	1.20	1	0	0.0	0.00	1.0e+00	GPX1
Impedance of whole body	2.22	32	24	53.3	0.19	2.8e-01	ADAMTS8 ADM ARL17A AS3MT C10orf26 CERS5 CNNM2 DCAF12 DCAKD DKFZp686O24166 FAM108C1 FDFT1 FMNL1 GPX1 HELLS HOXC8 LIME1 LRRC37A4P LSP1 MAPT NOC3L NT5C2 PMS2L3 RP11-296I10.6 RP5-890O3.9 RPS6KB1 SENP3 SNX32 SWAP70 TMEM110 TNFSF12-TNFSF13 WNT2B
Leg fat mass (left)	1.86	21	10	22.2	0.21	3.7e-01	ABHD17C AS3MT C10orf26 CDK6 CLCN6 CNNM2 CYP17A1-AS1 EDEM3 FAM108C1 FDFT1 GPX1 LOC100129961 MPP6 PMS2L3 RP11-296I10.6 RP5-890O3.9 SLC5A11 SLC9A3R2 SNX32 STXBP5 WNT2B
Arm predicted mass (left)	2.23	30	19	42.2	-0.45	1.3e-02	ADM ARHGAP24 AS3MT C10orf26 CDK6 CNNM2 CYP17A1-AS1 DCAF16 DCAKD FAM108C1 FDFT1 GATAD1 GLYR1 GPX1 LIME1 NOV PMS2L3 RP11-332H18.4 RP5-890O3.9 SENP3 SH2B3 SLC5A11 SLC9A3R2 SNX32 TCP11 TMBIM1 TMEM110 TNFSF12-TNFSF13 UPF3A USP36

Associations by panel

study	tissue	# hits	% hits/tests	avg chisq
GTEx	Adipose Subcutaneous	38	1.09	3.0
GTEx	Adipose Visceral Omentum	29	1.42	3.2
GTEx	Adrenal Gland	21	1.44	3.0
GTEx	Artery Aorta	52	1.75	3.4
GTEx	Artery Coronary	19	1.61	3.3
GTEx	Artery Tibial	55	1.46	3.3
GTEx	Brain Caudate basal ganglia	10	1.09	3.1
GTEx	Brain Cerebellar Hemisphere	22	1.48	3.2
GTEx	Brain Cerebellum	30	1.51	3.2
GTEx	Brain Cortex	14	1.35	3.1
GTEx	Brain Frontal Cortex BA9	19	2.06	3.4
GTEx	Brain Hippocampus	4	0.76	3.0
GTEx	Brain Hypothalamus	5	0.85	2.9
GTEx	Brain Nucleus accumbens basal ganglia	13	1.50	3.0
GTEx	Brain Putamen basal ganglia	8	1.28	3.0
GTEx	Breast Mammary Tissue	35	1.77	3.1
GTEx	Breast Mammary Tissue (Male)	12	1.01	3.1
GTEx	Breast Mammary Tissue (Female)	20	1.22	3.0
GTEx	Cells EBV-transformed lymphocytes	21	1.48	3.2
GTEx	Cells Transformed fibroblasts	48	1.14	2.9
GTEx	Colon Sigmoid	23	1.57	3.2
GTEx	Colon Transverse	29	1.41	3.0
GTEx	Esophagus Gastroesophageal Junction	28	1.94	3.4
GTEx	Esophagus Mucosa	38	1.14	3.0
GTEx	Esophagus Muscularis	41	1.27	3.0
GTEx	Heart Atrial Appendage	20	1.27	3.0
GTEx	Heart Left Ventricle	18	1.18	3.1
GTEx	Liver	8	1.12	2.9
GTEx	Lung	37	1.29	3.0
GTEx	Muscle Skeletal	33	1.14	3.1
GTEx	Nerve Tibial	50	1.16	2.9
GTEx	Ovary	18	1.98	3.2
GTEx	Pancreas	27	1.65	3.2
GTEx	Pituitary	13	1.17	3.0
GTEx	Prostate	14	1.68	3.4
GTEx	Skin Not Sun Exposed Suprapubic	28	1.14	3.1
GTEx	Skin Sun Exposed Lower leg	47	1.29	3.0
GTEx	Small Intestine Terminal Ileum	8	1.74	3.2
GTEx	Spleen	15	1.06	3.1
GTEx	Stomach	28	1.93	3.5
GTEx	Testis	44	1.39	3.0
GTEx	Thyroid	50	1.25	2.9
GTEx	Uterus	10	1.76	2.8
GTEx	Vagina	9	1.42	3.2
GTEx	Whole Blood	21	1.05	2.9
METSIM	Adipose	28	0.61	2.6
NTR	Blood	22	0.92	2.8
ROSMAP	Brain Pre-frontal Cortex	52	1.18	3.1
YFS	Blood	34	0.74	2.6
CommonMind	Brain Pre-frontal Cortex	60	1.12	2.8
The Cancer Genome Atlas	Bladder Urothelial Carcinoma	21	1.27	2.8
The Cancer Genome Atlas	Breast Invasive Carcinoma	46	1.04	2.7
The Cancer Genome Atlas	Cervical Squamous Cell Carcinoma	5	0.46	2.7
The Cancer Genome Atlas	Colon Adenocarcinoma	19	0.92	2.8
The Cancer Genome Atlas	Esophageal Carcinoma	11	1.61	2.7
The Cancer Genome Atlas	Glioblastoma Multiforme	10	0.98	2.7
The Cancer Genome Atlas	Head and Neck Squamous Cell Carcinoma	26	0.96	2.8
The Cancer Genome Atlas	Kidney Renal Clear Cell Carcinoma	47	1.15	2.9
The Cancer Genome Atlas	Kidney Renal Papillary Cell Carcinoma	21	1.02	2.9
The Cancer Genome Atlas	Brain Lower Grade Glioma	34	0.79	2.6
The Cancer Genome Atlas	Liver Hepatocellular Carcinoma	9	0.81	2.5
The Cancer Genome Atlas	Lung Adenocarcinoma	30	1.02	2.7
The Cancer Genome Atlas	Lung Squamous Cell Carcinoma	24	0.96	2.7
The Cancer Genome Atlas	Ovarian Serous Cystadenocarcinoma	15	0.94	2.7
The Cancer Genome Atlas	Pancreatic Adenocarcinoma	21	1.26	2.9
The Cancer Genome Atlas	Pheochromocytoma and Paraganglioma	14	1.06	2.7
The Cancer Genome Atlas	Prostate Adenocarcinoma	30	0.65	2.6
The Cancer Genome Atlas	Rectum Adenocarcinoma	7	1.01	2.8
The Cancer Genome Atlas	Soft Tissue Sarcoma	7	0.66	2.6
The Cancer Genome Atlas	Skin Cutaneous Melanoma	8	1.50	3.0
The Cancer Genome Atlas	Stomach Adenocarcinoma	15	0.89	2.8
The Cancer Genome Atlas	Testicular Germ Cell Tumors	17	1.33	2.8
The Cancer Genome Atlas	Thyroid Carcinoma	41	0.79	2.7
The Cancer Genome Atlas	Uterine Corpus Endometrial Carcinoma	6	1.18	2.8